| Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study P Baliakas, A Hadzidimitriou, LA Sutton, E Minga, A Agathangelidis, ... The lancet haematology 1 (2), e74-e84, 2014 | 158 | 2014 |
| Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations P Baliakas, A Agathangelidis, A Hadzidimitriou, LA Sutton, E Minga, ... Blood, The Journal of the American Society of Hematology 125 (5), 856-859, 2015 | 102 | 2015 |
| Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death MA Andersen, FJ Vojdeman, MK Andersen, PN Brown, CH Geisler, ... Leukemia & lymphoma 57 (7), 1592-1599, 2016 | 51 | 2016 |
| Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct immunogenetic features and clinical outcomes A Xochelli, P Baliakas, I Kavakiotis, A Agathangelidis, LA Sutton, E Minga, ... Clinical Cancer Research 23 (17), 5292-5301, 2017 | 43 | 2017 |
| Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark FJ Vojdeman, CM Madsen, K Frederiksen, D Durup, A Olsen, L Hansen, ... International Journal of Cancer 145 (2), 338-346, 2019 | 36 | 2019 |
| Vitamin D levels and the risk of prostate cancer and prostate cancer mortality HV Stroomberg, FJ Vojdeman, CM Madsen, JT Helgstrand, P Schwarz, ... Acta Oncologica 60 (3), 316-322, 2021 | 32 | 2021 |
| No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets# 1 and# 2 treated with chemo (immuno) therapy P Baliakas, M Mattsson, A Hadzidimitriou, E Minga, A Agathangelidis, ... Haematologica 103 (4), e158, 2018 | 25 | 2018 |
| Comorbidity and mortality after hip fracture in nineteen thousand six hundred and eighty two patients aged eighteen to sixty five years in Denmark from 1996 to 2012 A Omari, CM Madsen, JB Lauritzen, HL Jørgensen, FJ Vojdeman International Orthopaedics 43, 2621-2627, 2019 | 23 | 2019 |
| Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia FJ Vojdeman, SEM Herman, N Kirkby, A Wiestner, MB van t’Veer, ... Leukemia & lymphoma 58 (10), 2356-2362, 2017 | 19 | 2017 |
| Excess mortality following hip fracture in patients with diabetes according to age: a nationwide population-based cohort study of 154,047 hip fracture patients CM Madsen, C Jantzen, D Norring-Agerskov, FJ Vojdeman, ... Age and Ageing 48 (4), 559-563, 2019 | 18 | 2019 |
| DPYD genotyping and dihydropyrimidine dehydrogenase (DPD) phenotyping in clinical oncology. A clinically focused minireview NH Paulsen, F Vojdeman, SE Andersen, TK Bergmann, M Ewertz, ... Basic & Clinical Pharmacology & Toxicology 131 (5), 325-346, 2022 | 12 | 2022 |
| The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia FJ Vojdeman, MB Van't Veer, GE Tjønnfjord, M Itälä-Remes, E Kimby, ... Leukemia & lymphoma 58 (3), 594-600, 2017 | 11 | 2017 |
| Chronic lymphocytic leukaemia clones are detectable decades before diagnosis. FJ Vojdeman, J Helby, LB Pedersen, C Brieghel, MA Andersen, ... British Journal of Haematology 196 (3), 2022 | 6 | 2022 |
| Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants … NH Paulsen, C Qvortrup, FJ Vojdeman, P Plomgaard, SE Andersen, ... Acta Oncologica 61 (11), 1400-1405, 2022 | 5 | 2022 |
| Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. Lancet Haematol 2014; 1 (2): e74-84 P Baliakas, A Hadzidimitriou, LA Sutton, E Minga, A Agathangelidis, ... Go to original source... Go to PubMed, 0 | 4 | |
| Det danske screeningsprogram for hæmoglobinopatier A Glenthøj, M Samson, N Toft, BR Diness, N Askjær, FJ Vojdeman, ... Ugeskr Laeger 183, V07200536, 2021 | 3 | 2021 |
| National vitamin D intoxication outbreak among infants due to a manufacturing error of vitamin D droplets: challenges for the healthcare system S Bogevig, LCG Hoegberg, AJ Schou, IM Schmidt, FJ Vojdeman, ... Clinical Toxicology 55 (5), 385-386, 2017 | 3 | 2017 |
| Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis FJ Vojdeman, J Jurlander, M Veer, M Itälä-Remes, E Kimby, ... Leukemia & lymphoma 54 (4), 790-793, 2013 | 3 | 2013 |
| Diagnosing von Willebrand disease FJ Vojdeman, M Philips, E Funding, JP Gøtze Ugeskrift for Laeger 181 (16), V12180877-V12180877, 2019 | 2 | 2019 |
| Brief report: CD52 expression on CD4+ T cells in HIV-positive individuals on cART FJ Vojdeman, JC Gaardbo, HJ Hartling, M Gelpi, M Hove-Skovsgaard, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 77 (2), 217-220, 2018 | 2 | 2018 |
